FRANCE 24Cuba launches first nanopharmaceuticalFRANCE 24Cuba has unveiled its first manufactured nanopharmaceutical drug — a tweaked variety of cyclosporine, used to help prevent transplant rejection — official media reported Saturday. AFP – Cuba has…
Cuba launches nanopharmaceutical drugThe AustralianCUBA has unveiled its first manufactured nanopharmaceutical drug – a tweaked variety of cyclosporine, used to help prevent transplant rejection – official media reported. "Its main advantages are …
Cuba launches nanopharmaceutical drugHerald SunCUBA has unveiled its first manufactured nanopharmaceutical drug – a tweaked variety of cyclosporine, used to help prevent transplant rejection – official media reported. "Its main advantages are that…
Half-Match Bone Marrow Transplants Wipe Out Sickle Cell Disease in Selected …HealthCanal.comFuchs, Luznik, Brodsky and Jones are listed as inventors on a patent application regarding the “use of high-dose, post-transplantation oxazaphosphorine drug…
Tonix Pharmaceuticals Highlights Therapeutic Programs on CEONEWS.TvEquities.comDr. Lederman's past accomplishments include the elucidation of the molecular basis of T cell helper function, which led to the development of therapeutic candidates for …
IJN: Hui Yi was stable during last check-upThe Star OnlineThe statement added that according to international data, the most common cause of death for heart transplant recipients between three and five years, were coronary artery disease (14.5%), acute…
Thermo Fisher Scientific completes One Lambda takeoverZenopaOne Lambda's portfolio includes a range of diagnostic tests for use in determining the compatibility of donors and recipients pre-transplant, as well as for the detection of antibodies tha…
Rigel to Present at UBS Global Life Sciences ConferenceSacramento Bee… R343, an inhaled SYK inhibitor for asthma and R333, a topical JAK/SYK inhibitor for discoid lupus – both of which have commenced Phase 2 clinical trials; and R548, an oral JAK3 …
IO Informatics Partners with PROOF to Develop Risk Assessment Software for …GenomeWebStanley's firm has also worked with PROOF in the past to identify patterns that indicate which patients are at risk of organ transplant rejection, as well as to …
Thermo Fisher closes acquisition of One LambdaBusinessweekThe privately held company's diagnostic tests are used by transplant centers mostly to determine the compatibility of donors and recipients before a transplant occurs. They are also used to …